| Name | calaxin |
| Description | Predicted to enable calcium ion binding activity. Predicted to be involved in several processes, including cilium movement; outer dynein arm assembly; and regulation of flagellated sperm motility. Predicted to be located in cilium. Implicated in primary ciliary dyskinesia. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n CLXN (calaxin) is a calcium‐binding protein that functions as a regulator linking Ca²⁺ signaling to the activity of motor proteins. Initially characterized for its role in modulating the beat of sperm flagella through Ca²⁺‐dependent regulation of dynein activity"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ", CLXN serves as a molecular sensor that translates fluctuations in intracellular Ca²⁺ into alterations in motility. Although its best‐known function is in the control and timing of flagellar or ciliary motion, similar EF‐hand calcium‐binding proteins have been implicated in broader cellular processes. For example, dysregulation of related Ca²⁺‐binding molecules has been associated with oncogenic processes in breast cancer and lung adenocarcinoma, where altered expression can promote proliferation, migration, and invasion."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " Likewise, epigenetic studies have identified aberrant methylation signatures affecting such calcium signaling components across multiple tumor types, reinforcing the importance of Ca²⁺‐regulated pathways in cell differentiation, tissue organization, and disease progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, CLXN (calaxin) acts as a pivotal Ca²⁺ sensor that modulates motor protein function and thereby influences cellular motility. Its activity exemplifies how calcium‐dependent regulation of the cytoskeleton can be harnessed both in normal physiological events such as the control of flagellar beat, and in pathological conditions where disruption of such signaling may contribute to cancer progression and other disease states.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Keita Sasaki, Kogiku Shiba, Akihiro Nakamura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Calaxin is required for cilia-driven determination of vertebrate laterality."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Commun Biol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s42003-019-0462-y"}], "href": "https://doi.org/10.1038/s42003-019-0462-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31240264"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31240264"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Youzhi Zhu, Qingshui Wang, Yun Xia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-020-07125-4"}], "href": "https://doi.org/10.1186/s12885-020-07125-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32650755"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32650755"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Xiang Yang, Wenjing Shi, Xiaolou Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Low-level EFCAB1 promoted progress by upregulated DNMT3B and could be as a potential biomarker in lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Lab Anal (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcla.24166"}], "href": "https://doi.org/10.1002/jcla.24166"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34904288"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34904288"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Kentaro Ohara, Eri Arai, Yoriko Takahashi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genes involved in development and differentiation are commonly methylated in cancers derived from multiple organs: a single-institutional methylome analysis using 1007 tissue specimens."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgw209"}], "href": "https://doi.org/10.1093/carcin/bgw209"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28069692"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28069692"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yosuke Yamawaki, Norika Yoshioka, Kanako Nozaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sodium butyrate abolishes lipopolysaccharide-induced depression-like behaviors and hippocampal microglial activation in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.brainres.2017.12.004"}], "href": "https://doi.org/10.1016/j.brainres.2017.12.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29229502"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29229502"}]}]}]}
|
| NCBI Gene ID | 79645 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
CLXN has 1,374 functional associations with biological entities spanning 5 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 20 datasets.
Click the + buttons to view associations for CLXN from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of CLXN gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of CLXN gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with CLXN gene from the CellMarker Gene-Cell Type Associations dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of CLXN gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing CLXN protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with CLXN protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving CLXN gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing CLXN protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by CLXN gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of CLXN gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with CLXN gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of CLXN gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of CLXN gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of CLXN gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of CLXN gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of CLXN gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of CLXN gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of CLXN protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of CLXN protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with CLXN protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |